Background Highly active antiretroviral therapy (HAART) has led to health benefits for
patients infected with HIV-1. However, long-term use of multidrug regimens is difficult to …

Background The long-term effectiveness of potent three-drug antiretroviral regimens for the
treatment of human immunodeficiency virus type 1 (HIV-1) infection is limited by problems …

Structured treatment interruptions to control HIV-1 infection Page 1 RESEARCH LETTERS Our
results show that a single post-injury injection of autoimmune T cells directed against the CNS …

Background Early assessment of antiretroviral drug efficacy is important for prevention of the
emergence of drug-resistant virus and unnecessary exposure to ineffective drug regimens …

Background The optimal sequencing of antiretroviral regimens for the treatment of infection
with human immunodeficiency virus type 1 (HIV-1) is unknown. We compared several …

ContextIn the Trilège trial, following induction with a zidovudine, lamivudine, and indinavir
regimen, human immunodeficiency virus (HIV) replication was less suppressed by 2-drug …

Background Short-course antiretroviral therapy (ART) in primary human immunodeficiency
virus (HIV) infection may delay disease progression but has not been adequately evaluated …

Context.—Combination antiretroviral therapy can markedly suppress human
immunodeficiency virus (HIV) replication but the duration of HIV suppression varies among …

Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …

Background: Scheduled treatment interruptions are being evaluated in an effort to decrease
costs and side effects of highly active antiretroviral therapy (HAART). A schedule of 1 week …